Indeed, given that BCL2 is a prime target for cancer treatment, the top compounds identified in this study could be validated through various cell culture experiments, such as cell viability assays, caspase activation tests, mRNA expression profiling, and other validation tests, to assess their anticancer potential. This evidence concerns the gene BCL2 and cancer.